Immunoprotective efficacy of Acinetobacter baumannii outer membrane protein, FilF, predicted in silico as a potential vaccine candidate

Acinetobacter baumannii is emerging as a serious nosocomial pathogen with multidrug resistance that has made it difficult to cure and development of efficacious treatment against this pathogen is direly needed. This has led to investigate vaccine approach to prevent and treat A. baumannii infections...

Full description

Bibliographic Details
Main Authors: Ravinder eSingh, Nisha eGarg, Geeta eShukla, Neena eCapalash, Prince eSharma
Format: Article
Language:English
Published: Frontiers Media S.A. 2016-02-01
Series:Frontiers in Microbiology
Subjects:
Online Access:http://journal.frontiersin.org/Journal/10.3389/fmicb.2016.00158/full
_version_ 1811344108920242176
author Ravinder eSingh
Nisha eGarg
Geeta eShukla
Neena eCapalash
Prince eSharma
author_facet Ravinder eSingh
Nisha eGarg
Geeta eShukla
Neena eCapalash
Prince eSharma
author_sort Ravinder eSingh
collection DOAJ
description Acinetobacter baumannii is emerging as a serious nosocomial pathogen with multidrug resistance that has made it difficult to cure and development of efficacious treatment against this pathogen is direly needed. This has led to investigate vaccine approach to prevent and treat A. baumannii infections. In this work, an outer membrane putative pilus assembly protein, FilF, was predicted as vaccine candidate by in silico analysis of A. baumannii proteome and was found to be conserved among the A. baumannii strains. It was cloned and expressed in E. coli BL21(DE3) and purified by Ni-NTA chromatography. Immunization with FilF generated high antibody titer (>64000) and provided 50% protection against a standardized lethal dose (10*8 CFU) of A. baumannii in murine pneumonia model. FilF immunization reduced the bacterial load in lungs by 2 and 4 log cycles, 12 and 24 h post infection as compared to adjuvant control; reduced the levels of pro-inflammatory cytokines TNF-α, IL-6, IL-33, IFN-γ and IL-1β significantly and histology of lung tissue supported the data by showing considerably reduced damage and infiltration of neutrophils in lungs. These results demonstrate the in vivo validation of immunoprotective efficacy of a protein predicted as a vaccine candidate by in silico proteomic analysis and open the possibilities for exploration of a large array of uncharacterized proteins.
first_indexed 2024-04-13T19:41:57Z
format Article
id doaj.art-42862b219e8a4f438ca3e34d226f7eda
institution Directory Open Access Journal
issn 1664-302X
language English
last_indexed 2024-04-13T19:41:57Z
publishDate 2016-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Microbiology
spelling doaj.art-42862b219e8a4f438ca3e34d226f7eda2022-12-22T02:32:52ZengFrontiers Media S.A.Frontiers in Microbiology1664-302X2016-02-01710.3389/fmicb.2016.00158176142Immunoprotective efficacy of Acinetobacter baumannii outer membrane protein, FilF, predicted in silico as a potential vaccine candidateRavinder eSingh0Nisha eGarg1Geeta eShukla2Neena eCapalash3Prince eSharma4Department of Microbiology, Panjab UniversityDepartment of Microbiology, Panjab UniversityDepartment of Microbiology, Panjab UniversityDepartment of Biotechnology, Panjab UniversityDepartment of Microbiology, Panjab UniversityAcinetobacter baumannii is emerging as a serious nosocomial pathogen with multidrug resistance that has made it difficult to cure and development of efficacious treatment against this pathogen is direly needed. This has led to investigate vaccine approach to prevent and treat A. baumannii infections. In this work, an outer membrane putative pilus assembly protein, FilF, was predicted as vaccine candidate by in silico analysis of A. baumannii proteome and was found to be conserved among the A. baumannii strains. It was cloned and expressed in E. coli BL21(DE3) and purified by Ni-NTA chromatography. Immunization with FilF generated high antibody titer (>64000) and provided 50% protection against a standardized lethal dose (10*8 CFU) of A. baumannii in murine pneumonia model. FilF immunization reduced the bacterial load in lungs by 2 and 4 log cycles, 12 and 24 h post infection as compared to adjuvant control; reduced the levels of pro-inflammatory cytokines TNF-α, IL-6, IL-33, IFN-γ and IL-1β significantly and histology of lung tissue supported the data by showing considerably reduced damage and infiltration of neutrophils in lungs. These results demonstrate the in vivo validation of immunoprotective efficacy of a protein predicted as a vaccine candidate by in silico proteomic analysis and open the possibilities for exploration of a large array of uncharacterized proteins.http://journal.frontiersin.org/Journal/10.3389/fmicb.2016.00158/fullAcinetobacter baumanniiCytokinesVaccinereverse vaccinologyImmunoprotectionOMP
spellingShingle Ravinder eSingh
Nisha eGarg
Geeta eShukla
Neena eCapalash
Prince eSharma
Immunoprotective efficacy of Acinetobacter baumannii outer membrane protein, FilF, predicted in silico as a potential vaccine candidate
Frontiers in Microbiology
Acinetobacter baumannii
Cytokines
Vaccine
reverse vaccinology
Immunoprotection
OMP
title Immunoprotective efficacy of Acinetobacter baumannii outer membrane protein, FilF, predicted in silico as a potential vaccine candidate
title_full Immunoprotective efficacy of Acinetobacter baumannii outer membrane protein, FilF, predicted in silico as a potential vaccine candidate
title_fullStr Immunoprotective efficacy of Acinetobacter baumannii outer membrane protein, FilF, predicted in silico as a potential vaccine candidate
title_full_unstemmed Immunoprotective efficacy of Acinetobacter baumannii outer membrane protein, FilF, predicted in silico as a potential vaccine candidate
title_short Immunoprotective efficacy of Acinetobacter baumannii outer membrane protein, FilF, predicted in silico as a potential vaccine candidate
title_sort immunoprotective efficacy of acinetobacter baumannii outer membrane protein filf predicted in silico as a potential vaccine candidate
topic Acinetobacter baumannii
Cytokines
Vaccine
reverse vaccinology
Immunoprotection
OMP
url http://journal.frontiersin.org/Journal/10.3389/fmicb.2016.00158/full
work_keys_str_mv AT ravinderesingh immunoprotectiveefficacyofacinetobacterbaumanniioutermembraneproteinfilfpredictedinsilicoasapotentialvaccinecandidate
AT nishaegarg immunoprotectiveefficacyofacinetobacterbaumanniioutermembraneproteinfilfpredictedinsilicoasapotentialvaccinecandidate
AT geetaeshukla immunoprotectiveefficacyofacinetobacterbaumanniioutermembraneproteinfilfpredictedinsilicoasapotentialvaccinecandidate
AT neenaecapalash immunoprotectiveefficacyofacinetobacterbaumanniioutermembraneproteinfilfpredictedinsilicoasapotentialvaccinecandidate
AT princeesharma immunoprotectiveefficacyofacinetobacterbaumanniioutermembraneproteinfilfpredictedinsilicoasapotentialvaccinecandidate